Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Satomi Hiya, Hajime Yoshimura, Michi Kawamoto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-06-01
coleção:	eNeurologicalSci
Assuntos:	Myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) Adolescent Neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis (MS) Ofatumumab
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2405650223000199
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!